Mycor

Mycor (MYCOR GmbH) is a German medical technology company specializing in the early detection of cardiac amyloidosis through artificial intelligence. The company's core technology is the SYGNAL algorithm, a non-invasive screening tool that analyzes 3D ECG loop signals to identify patients at risk of amyloidosis with high accuracy. Founded by a team of cardiologists and researchers from the University Hospital Essen, Mycor aims to improve patient outcomes by enabling earlier diagnosis of a condition that is often underdiagnosed. The SYGNAL platform is designed for easy integration into primary healthcare settings, requiring only a standard four-lead ECG.